209 related articles for article (PubMed ID: 20228169)
1. Long-term ritonavir exposure increases fatty acid and glycerol recycling in 3T3-L1 adipocytes as compensatory mechanisms for increased triacylglycerol hydrolysis.
Adler-Wailes DC; Guiney EL; Wolins NE; Yanovski JA
Endocrinology; 2010 May; 151(5):2097-105. PubMed ID: 20228169
[TBL] [Abstract][Full Text] [Related]
2. 1,25-Dihydroxyvitamin D regulates lipid metabolism and glucose utilization in differentiated 3T3-L1 adipocytes.
Larrick BM; Kim KH; Donkin SS; Teegarden D
Nutr Res; 2018 Oct; 58():72-83. PubMed ID: 30340817
[TBL] [Abstract][Full Text] [Related]
3. Ritonavir increases the level of active ADD-1/SREBP-1 protein during adipogenesis.
Nguyen AT; Gagnon A; Angel JB; Sorisky A
AIDS; 2000 Nov; 14(16):2467-73. PubMed ID: 11101056
[TBL] [Abstract][Full Text] [Related]
4. Distinct long-term regulation of glycerol and non-esterified fatty acid release by insulin and TNF-alpha in 3T3-L1 adipocytes.
Rosenstock M; Greenberg AS; Rudich A
Diabetologia; 2001 Jan; 44(1):55-62. PubMed ID: 11206412
[TBL] [Abstract][Full Text] [Related]
5. The effect of the HIV protease inhibitor ritonavir on proliferation, differentiation, lipogenesis, gene expression and apoptosis of human preadipocytes and adipocytes.
Grigem S; Fischer-Posovszky P; Debatin KM; Loizon E; Vidal H; Wabitsch M
Horm Metab Res; 2005 Oct; 37(10):602-9. PubMed ID: 16278782
[TBL] [Abstract][Full Text] [Related]
6. Microarray Analysis Reveals Altered Lipid and Glucose Metabolism Genes in Differentiated, Ritonavir-Treated 3T3-L1 Adipocytes.
Loonam CR; O'Dell SD; Sharp PA; Mullen A
Curr HIV Res; 2016; 14(1):37-46. PubMed ID: 26245760
[TBL] [Abstract][Full Text] [Related]
7. Reduced SCD1 activity alters markers of fatty acid reesterification, glyceroneogenesis, and lipolysis in murine white adipose tissue and 3T3-L1 adipocytes.
Dragos SM; Bergeron KF; Desmarais F; Suitor K; Wright DC; Mounier C; Mutch DM
Am J Physiol Cell Physiol; 2017 Sep; 313(3):C295-C304. PubMed ID: 28659287
[TBL] [Abstract][Full Text] [Related]
8. Palmitoleic acid (n-7) increases white adipocyte lipolysis and lipase content in a PPARα-dependent manner.
Bolsoni-Lopes A; Festuccia WT; Farias TS; Chimin P; Torres-Leal FL; Derogis PB; de Andrade PB; Miyamoto S; Lima FB; Curi R; Alonso-Vale MI
Am J Physiol Endocrinol Metab; 2013 Nov; 305(9):E1093-102. PubMed ID: 24022867
[TBL] [Abstract][Full Text] [Related]
9. Glucose enhances catecholamine-stimulated lipolysis via increased glycerol-3-phosphate synthesis in 3T3-L1 adipocytes and rat adipose tissue.
Takeuchi N; Higashida K; Li X; Nakai N
Mol Biol Rep; 2021 Sep; 48(9):6269-6276. PubMed ID: 34374898
[TBL] [Abstract][Full Text] [Related]
10. Antiretroviral drugs with adverse effects on adipocyte lipid metabolism and survival alter the expression and secretion of proinflammatory cytokines and adiponectin in vitro.
Lagathu C; Bastard JP; Auclair M; Maachi M; Kornprobst M; Capeau J; Caron M
Antivir Ther; 2004 Dec; 9(6):911-20. PubMed ID: 15651750
[TBL] [Abstract][Full Text] [Related]
11. Medium-chain Fatty acids attenuate agonist-stimulated lipolysis, mimicking the effects of starvation.
Lei T; Xie W; Han J; Corkey BE; Hamilton JA; Guo W
Obes Res; 2004 Apr; 12(4):599-611. PubMed ID: 15090627
[TBL] [Abstract][Full Text] [Related]
12. Altered adipokine response in murine 3T3-F442A adipocytes treated with protease inhibitors and nucleoside reverse transcriptase inhibitors.
Jones SP; Janneh O; Back DJ; Pirmohamed M
Antivir Ther; 2005; 10(2):207-13. PubMed ID: 15865214
[TBL] [Abstract][Full Text] [Related]
13. The potential effects of ethyl acetate fraction from Curcuma longa L. on lipolysis in differentiated 3T3-L1 adipocytes.
Lee J; Yoon HG; Lee YH; Park J; You Y; Kim K; Jang JY; Yang JW; Jun W
J Med Food; 2010 Apr; 13(2):364-70. PubMed ID: 20412020
[TBL] [Abstract][Full Text] [Related]
14. Curcumin attenuates lipolysis stimulated by tumor necrosis factor-α or isoproterenol in 3T3-L1 adipocytes.
Xie XY; Kong PR; Wu JF; Li Y; Li YX
Phytomedicine; 2012 Dec; 20(1):3-8. PubMed ID: 23083815
[TBL] [Abstract][Full Text] [Related]
15. Analysis of lipolysis in adipocytes using a fluorescent fatty acid derivative.
Müller G; Jordan H; Jung C; Kleine H; Petry S
Biochimie; 2003 Dec; 85(12):1245-56. PubMed ID: 14739077
[TBL] [Abstract][Full Text] [Related]
16. The ginsenoside-Rb2 lowers cholesterol and triacylglycerol levels in 3T3-L1 adipocytes cultured under high cholesterol or fatty acids conditions.
Kim EJ; Lee HI; Chung KJ; Noh YH; Ro Y; Koo JH
BMB Rep; 2009 Apr; 42(4):194-9. PubMed ID: 19403041
[TBL] [Abstract][Full Text] [Related]
17. Effects of the human immunodeficiency virus-protease inhibitor, ritonavir, on basal and catecholamine-stimulated lipolysis.
Adler-Wailes DC; Liu H; Ahmad F; Feng N; Londos C; Manganiello V; Yanovski JA
J Clin Endocrinol Metab; 2005 Jun; 90(6):3251-61. PubMed ID: 15741249
[TBL] [Abstract][Full Text] [Related]
18. Palmitoleic acid (16:1n7) increases oxygen consumption, fatty acid oxidation and ATP content in white adipocytes.
Cruz MM; Lopes AB; Crisma AR; de Sá RCC; Kuwabara WMT; Curi R; de Andrade PBM; Alonso-Vale MIC
Lipids Health Dis; 2018 Mar; 17(1):55. PubMed ID: 29554895
[TBL] [Abstract][Full Text] [Related]
19. Acute and selective inhibition of adipocyte glyceroneogenesis and cytosolic phosphoenolpyruvate carboxykinase by interferon gamma.
Khazen W; Distel E; Collinet M; Chaves VE; M'Bika JP; Chany C; Achour A; Benelli C; Forest C
Endocrinology; 2007 Aug; 148(8):4007-14. PubMed ID: 17495004
[TBL] [Abstract][Full Text] [Related]
20. Differential effect of HIV protease inhibitors on adipogenesis: intracellular ritonavir is not sufficient to inhibit differentiation.
Vernochet C; Azoulay S; Duval D; Guedj R; Ailhaud G; Dani C
AIDS; 2003 Oct; 17(15):2177-80. PubMed ID: 14523274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]